Results 141 to 150 of about 40,504 (198)

Clinical and biological risk factors influencing infant HIV status: a case study of Kisenyi Health Center IV, Kampala, Uganda. [PDF]

BMC Infect Dis
Bagonza FX, Asiimwe JB, Wamono F, Nsimbe D.   +3 more
europepmc   +1 more source

Detection of active pharmaceutical ingredients in surface water polluted by an informal settlement. [PDF]

Environ Monit Assess
Maraj K, Nicklin E, Edmonds-Smith C, Winter K.   +3 more
europepmc   +1 more source

ABCB1 Polymorphism in HIV-Infected Individuals Taking Antiretroviral Drugs. [PDF]

AIDS Res Treat
Singh H, Samani D, Mahajan SD.
europepmc   +1 more source

Recoverability of causal effects under presence of missing data: a longitudinal case study. [PDF]

Biostatistics
Holovchak A, McIlleron H, Denti P, Schomaker M.   +3 more
europepmc   +1 more source

Physiologically-Based Pharmacokinetic Model-Informed Labeling for Cariprazine Drug Interactions With CYP3A Inhibitors. [PDF]

CPT Pharmacometrics Syst Pharmacol
Riad MMH, Marroum P, Shebley M, Xiong H.
europepmc   +1 more source

Efficacy and safety of efavirenz in Niemann-Pick disease type C. [PDF]

Neurotherapeutics
Gascón-Bayarri J, Rico I, Sánchez-Castañeda C, Ledesma MD, Carnaval T, Bejr-Kasem H, Campdelacreu J, Ferrer A, Rodríguez-Bel L, Cos M, de Lama E, López de Munain A, Rouco I, Pérez-Sousa C, Cerdán M, Muelas N, Sevillano MD, Mir P, Villoria J, Videla S.   +19 more
europepmc   +1 more source

Lipid nanocapsule-chitosan and iota-carrageenan hydrogel composite for sustained hydrophobic drug delivery. [PDF]

Sci Rep
Mukubwa GK, Safari JB, Tetana ZN, Jones CN, Walker RB, Krause RWM.   +5 more
europepmc   +1 more source

Efavirenz Interacts with Hormones Involved in Appetite and Satiety, Affecting Body Weight in Mice. [PDF]

Int J Mol Sci
Rojas-Osornio SA, Manuel-Apolinar L, Crespo-Ramírez M, Paredes-Cervantes V, Mata-Marín A, Molina-López J, Pérez de la Mora M, Borroto-Escuela D, Martínez-Lara R, Tesoro-Cruz E.   +9 more
europepmc   +1 more source

Viral suppression and adverse events following antiretroviral therapy optimization among children and adolescents in Uganda, 2018-2023. [PDF]

BMC Public Health
Ankunda C, Namasambi S, Kyomuhangi B, Emunyu J, Sserunjogi C, Nakaweesi J.   +5 more
europepmc   +1 more source